| Cosmas Onwudiwe Onuora, MD | |
|
4775 Higbee Ave Nw, Canton, OH 44718-2551 | |
| (330) 493-9940 | |
| (330) 493-9943 |
| Full Name | Cosmas Onwudiwe Onuora |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 39 Years |
| Location | 4775 Higbee Ave Nw, Canton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104856541 | NPI | - | NPPES |
| 0805310 | Medicaid | OH | |
| 000000138824 | Other | OH | ANTHEM |
| 730482 | Other | OH | BUCKEYE COMMUNITY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35060206O (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aultman Hospital | Canton, OH | Hospital |
| Entity Name | Aultman Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619911054 PECOS PAC ID: 3779485867 Enrollment ID: O20040121000010 |
News Archive
The researchers at the Swedish National Institute for Working Life looked at the mobile phone use of 2,200 cancer patients and an equal number of healthy control cases.
The ACC/AHA 2008 Task Force on Performance Measures' Statement on Performance Measurement and Reperfusion Therapy will webpost on Monday, November 10 at 2 pm ET.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).
HealthPort, an industry authority in the HIPAA-compliant transfer of protected health information and audit management technology, today announced its involvement as the largest health information handler approved to participate in the test phase of the Centers for Medicare & Medicaid Services' electronic submission of medical documentation gateway services for information exchange from healthcare providers.
› Verified 9 days ago
| Entity Name | Ohio Physician Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417016973 PECOS PAC ID: 2668406059 Enrollment ID: O20050925000062 |
News Archive
The researchers at the Swedish National Institute for Working Life looked at the mobile phone use of 2,200 cancer patients and an equal number of healthy control cases.
The ACC/AHA 2008 Task Force on Performance Measures' Statement on Performance Measurement and Reperfusion Therapy will webpost on Monday, November 10 at 2 pm ET.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).
HealthPort, an industry authority in the HIPAA-compliant transfer of protected health information and audit management technology, today announced its involvement as the largest health information handler approved to participate in the test phase of the Centers for Medicare & Medicaid Services' electronic submission of medical documentation gateway services for information exchange from healthcare providers.
› Verified 9 days ago
| Entity Name | Hall Of Fame Woman's Clinic,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669678942 PECOS PAC ID: 9931294634 Enrollment ID: O20070926000620 |
News Archive
The researchers at the Swedish National Institute for Working Life looked at the mobile phone use of 2,200 cancer patients and an equal number of healthy control cases.
The ACC/AHA 2008 Task Force on Performance Measures' Statement on Performance Measurement and Reperfusion Therapy will webpost on Monday, November 10 at 2 pm ET.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).
HealthPort, an industry authority in the HIPAA-compliant transfer of protected health information and audit management technology, today announced its involvement as the largest health information handler approved to participate in the test phase of the Centers for Medicare & Medicaid Services' electronic submission of medical documentation gateway services for information exchange from healthcare providers.
› Verified 9 days ago
| Entity Name | My Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588117147 PECOS PAC ID: 3971884636 Enrollment ID: O20170111003340 |
News Archive
The researchers at the Swedish National Institute for Working Life looked at the mobile phone use of 2,200 cancer patients and an equal number of healthy control cases.
The ACC/AHA 2008 Task Force on Performance Measures' Statement on Performance Measurement and Reperfusion Therapy will webpost on Monday, November 10 at 2 pm ET.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).
HealthPort, an industry authority in the HIPAA-compliant transfer of protected health information and audit management technology, today announced its involvement as the largest health information handler approved to participate in the test phase of the Centers for Medicare & Medicaid Services' electronic submission of medical documentation gateway services for information exchange from healthcare providers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cosmas Onwudiwe Onuora, MD 4775 Higbee Ave Nw, Canton, OH 44718-2551 Ph: (330) 493-9940 | Cosmas Onwudiwe Onuora, MD 4775 Higbee Ave Nw, Canton, OH 44718-2551 Ph: (330) 493-9940 |
News Archive
The researchers at the Swedish National Institute for Working Life looked at the mobile phone use of 2,200 cancer patients and an equal number of healthy control cases.
The ACC/AHA 2008 Task Force on Performance Measures' Statement on Performance Measurement and Reperfusion Therapy will webpost on Monday, November 10 at 2 pm ET.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection).
HealthPort, an industry authority in the HIPAA-compliant transfer of protected health information and audit management technology, today announced its involvement as the largest health information handler approved to participate in the test phase of the Centers for Medicare & Medicaid Services' electronic submission of medical documentation gateway services for information exchange from healthcare providers.
› Verified 9 days ago
Robert Hamilton Iii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1455 Harrison Ave Nw, Suite 202, Canton, OH 44708 Phone: 330-453-7339 Fax: 330-453-7345 | |
Timothy Eugene Mcdaniel, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2600 Sixth Street Sw, Aultman Hospital, Canton, OH 44710 Phone: 330-452-9911 Fax: 330-588-4717 | |
Randall S Starcher, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Higbee Ave Nw, Canton, OH 44718 Phone: 330-493-0313 Fax: 330-493-9349 | |
Julianne Yang Kar, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Higbee Ave Nw, Canton, OH 44718 Phone: 330-493-0313 Fax: 330-580-5513 | |
Dr. Jason Hoppe, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5000 Higbee Ave Nw, Canton, OH 44718 Phone: 330-493-0313 | |
Victor H Bazzoli, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2525 13th St Nw, Canton, OH 44708 Phone: 330-455-5231 Fax: 330-455-1403 |